Brief: Cymabay Reports Second Quarter And Six Months Ended June 30, 2021 Financial Results And Provides Corporate Update
Aug 12 (Reuters) - Cymabay Therapeutics Inc CBAY.O :
* CYMABAY REPORTS SECOND QUARTER AND SIX MONTHS ENDED JUNE
30,
2021 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* CYMABAY THERAPEUTICS - QTRLY LOSS PER SHARE $0.34
Source text for Eikon: ID:nGNX6jW7N2
Further company coverage: CBAY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CymaBay Therapeutics
See all newsBrief: CymaBay Says EMA Accepted For Review The Marketing Authorization Application For Seladelpar
U.S. RESEARCH ROUNDUP-Bruker Corp, Cymabay Therapeutics, SSR Mining
U.S. RESEARCH ROUNDUP-An2 Therapeutics, Par Technology, Trimble
U.S. STOCKS ON THE MOVE-Perpetua Resources, Nvidia, SiriusXM
U.S. STOCKS ON THE MOVE-Lowe's, Bit Digital Snap